CompletedNot Applicable

Increasing Engagement and Improving HIV Outcomes Via HealthMPowerment

United States750 participantsStarted 2020-07-07

Plain-language summary

The overall goal of this 3-arm randomized trial is to test whether a network-driven online intervention tailored for intersectional stigma amelioration can elicit online social support, promote intervention engagement, and mitigate the impact of multiple stigmas on HIV-related outcomes among young Black and/or Latino men who have sex with men and transgender women.

Who can participate

Age range

15 Years – 29 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ages 15-29 (inclusive); * Identify as Black/African American and/or Latino/Hispanic; * Be U.S. residents (verified by zip code); * Report at least one episode of condomless anal sex act with a man in prior 6 months; * Assigned male sex at birth; * Currently identifies as male or as woman * Have access to internet * Reports owning or having regular access to a smartphone device or laptop/tablet through which to log onto the study site. Exclusion Criteria: * Assigned female sex at birth * Aged 14 years or younger or 30 years or older at time of screening * Does not speak or read English or Spanish * Did not have consensual anal sex with a male partner in the prior 6 months * Does not reside in the United States * Currently incarcerated * Planning to move out of the United States in next 12 months

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Percent of Participants Reporting Changes in Their HIV Testing Behavior Using Self-report Questionnaires

Timeframe: 12 month

Percent of Participants Reporting Viral Suppression Using Self-Report Questionnaires

Timeframe: 12 month

Trial details

NCT IDNCT03678181

SponsorUniversity of Pennsylvania

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-10-15

Results submitted2024-08-26

View on ClinicalTrials.gov More HIV Infections trials